Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag AstraZeneca's strong earnings boost FTSE 100, while other companies show mixed results.

flag AstraZeneca reported strong first-half 2025 results, with revenue up 9.5% and pretax profit up 26%. flag Barclays also boosted earnings and announced a £1bn share buyback. flag However, Greggs saw a 14% drop in profit despite higher sales. flag The FTSE 100 index rose 0.53% on Tuesday, buoyed by positive earnings reports and the AstraZeneca boost. flag The healthcare sector saw mixed results, with AstraZeneca leading gains while other companies like Novo Nordisk underperformed.

12 Articles